

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tryptophan catabolic process (GO:0006569) | 5.16496061 |
| 2 | indole-containing compound catabolic process (GO:0042436) | 5.16496061 |
| 3 | indolalkylamine catabolic process (GO:0046218) | 5.16496061 |
| 4 | aromatic amino acid family catabolic process (GO:0009074) | 4.98773439 |
| 5 | urate metabolic process (GO:0046415) | 4.90127053 |
| 6 | tryptophan metabolic process (GO:0006568) | 4.84527367 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 4.84512018 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.84512018 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.73582661 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.73582661 |
| 11 | drug transmembrane transport (GO:0006855) | 4.66322808 |
| 12 | homocysteine metabolic process (GO:0050667) | 4.62637606 |
| 13 | protein K11-linked deubiquitination (GO:0035871) | 4.46715004 |
| 14 | cysteine metabolic process (GO:0006534) | 4.39820155 |
| 15 | serine family amino acid catabolic process (GO:0009071) | 4.38880757 |
| 16 | glyoxylate metabolic process (GO:0046487) | 4.37048275 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29898192 |
| 18 | drug transport (GO:0015893) | 4.14247986 |
| 19 | glycine metabolic process (GO:0006544) | 4.11380370 |
| 20 | serine family amino acid metabolic process (GO:0009069) | 4.06378793 |
| 21 | piRNA metabolic process (GO:0034587) | 4.04500814 |
| 22 | kynurenine metabolic process (GO:0070189) | 3.99497044 |
| 23 | cellular biogenic amine catabolic process (GO:0042402) | 3.95978852 |
| 24 | amine catabolic process (GO:0009310) | 3.95978852 |
| 25 | lysine catabolic process (GO:0006554) | 3.89148220 |
| 26 | lysine metabolic process (GO:0006553) | 3.89148220 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 3.88264752 |
| 28 | interferon-gamma production (GO:0032609) | 3.84118373 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 3.77773570 |
| 30 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76771949 |
| 31 | proline metabolic process (GO:0006560) | 3.74916390 |
| 32 | serine family amino acid biosynthetic process (GO:0009070) | 3.73422161 |
| 33 | indolalkylamine metabolic process (GO:0006586) | 3.72371253 |
| 34 | imidazole-containing compound metabolic process (GO:0052803) | 3.70950097 |
| 35 | NAD biosynthetic process (GO:0009435) | 3.59103492 |
| 36 | drug catabolic process (GO:0042737) | 3.57797708 |
| 37 | tetrahydrofolate metabolic process (GO:0046653) | 3.46491702 |
| 38 | branched-chain amino acid catabolic process (GO:0009083) | 3.34573885 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34400629 |
| 40 | multicellular organism reproduction (GO:0032504) | 3.32423769 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 3.32204962 |
| 42 | organic cation transport (GO:0015695) | 3.27102937 |
| 43 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.26365912 |
| 44 | adaptation of signaling pathway (GO:0023058) | 3.23818897 |
| 45 | bile acid metabolic process (GO:0008206) | 3.22615140 |
| 46 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.20273651 |
| 47 | bile acid biosynthetic process (GO:0006699) | 3.19316238 |
| 48 | folic acid-containing compound metabolic process (GO:0006760) | 3.18920402 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.18427306 |
| 50 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.18212280 |
| 51 | detection of light stimulus involved in visual perception (GO:0050908) | 3.18212280 |
| 52 | folic acid metabolic process (GO:0046655) | 3.17394008 |
| 53 | pteridine-containing compound metabolic process (GO:0042558) | 3.16605572 |
| 54 | branched-chain amino acid metabolic process (GO:0009081) | 3.16512762 |
| 55 | bile acid and bile salt transport (GO:0015721) | 3.15889387 |
| 56 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.15571440 |
| 57 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.15571440 |
| 58 | DNA methylation involved in gamete generation (GO:0043046) | 3.14798420 |
| 59 | carnitine metabolic process (GO:0009437) | 3.12712895 |
| 60 | exogenous drug catabolic process (GO:0042738) | 3.12389662 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 3.11126494 |
| 62 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.09969305 |
| 63 | DNA deamination (GO:0045006) | 3.08090474 |
| 64 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03893972 |
| 65 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.03882366 |
| 66 | glucocorticoid biosynthetic process (GO:0006704) | 3.01724135 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 3.00743339 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00206467 |
| 69 | regulation of acrosome reaction (GO:0060046) | 2.99315138 |
| 70 | sulfur amino acid biosynthetic process (GO:0000097) | 2.99093493 |
| 71 | cell wall macromolecule metabolic process (GO:0044036) | 2.98545369 |
| 72 | urea cycle (GO:0000050) | 2.97936988 |
| 73 | urea metabolic process (GO:0019627) | 2.97936988 |
| 74 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97603891 |
| 75 | sulfur amino acid catabolic process (GO:0000098) | 2.96738300 |
| 76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.94913018 |
| 77 | neural tube formation (GO:0001841) | 2.92667437 |
| 78 | negative regulation of interleukin-1 production (GO:0032692) | 2.91978301 |
| 79 | cell wall macromolecule catabolic process (GO:0016998) | 2.91821844 |
| 80 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.91416114 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 2.91316855 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 2.91126657 |
| 83 | one-carbon metabolic process (GO:0006730) | 2.90049979 |
| 84 | DNA integration (GO:0015074) | 2.89819017 |
| 85 | indole-containing compound metabolic process (GO:0042430) | 2.86878988 |
| 86 | nitrogen cycle metabolic process (GO:0071941) | 2.85082781 |
| 87 | RNA destabilization (GO:0050779) | 2.83591038 |
| 88 | adenosine metabolic process (GO:0046085) | 2.82106193 |
| 89 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81559548 |
| 90 | kinetochore assembly (GO:0051382) | 2.81272349 |
| 91 | positive regulation of mast cell activation (GO:0033005) | 2.80356785 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.79985435 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79985435 |
| 94 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.79826520 |
| 95 | glycerophospholipid catabolic process (GO:0046475) | 2.79575496 |
| 96 | sulfur amino acid metabolic process (GO:0000096) | 2.79436752 |
| 97 | aldehyde catabolic process (GO:0046185) | 2.79085321 |
| 98 | regulation of female gonad development (GO:2000194) | 2.78540110 |
| 99 | phosphate ion transport (GO:0006817) | 2.78367183 |
| 100 | proline biosynthetic process (GO:0006561) | 2.78212911 |
| 101 | regulation of meiosis I (GO:0060631) | 2.77450627 |
| 102 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.77293783 |
| 103 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.77106240 |
| 104 | carboxylic acid catabolic process (GO:0046395) | 2.75538584 |
| 105 | organic acid catabolic process (GO:0016054) | 2.75538584 |
| 106 | valine metabolic process (GO:0006573) | 2.74076465 |
| 107 | regulation of memory T cell differentiation (GO:0043380) | 2.73204864 |
| 108 | establishment of protein localization to Golgi (GO:0072600) | 2.72931080 |
| 109 | regulation of mast cell activation (GO:0033003) | 2.72742680 |
| 110 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.71031717 |
| 111 | reciprocal DNA recombination (GO:0035825) | 2.70793187 |
| 112 | reciprocal meiotic recombination (GO:0007131) | 2.70793187 |
| 113 | negative regulation of mast cell activation (GO:0033004) | 2.70341439 |
| 114 | microglial cell activation (GO:0001774) | 2.70319550 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 2.68937394 |
| 116 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.68694089 |
| 117 | negative regulation of cholesterol transport (GO:0032375) | 2.68667322 |
| 118 | negative regulation of sterol transport (GO:0032372) | 2.68667322 |
| 119 | regulation of helicase activity (GO:0051095) | 2.67071819 |
| 120 | benzene-containing compound metabolic process (GO:0042537) | 2.66383963 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.65752107 |
| 122 | activated T cell proliferation (GO:0050798) | 2.65601571 |
| 123 | retinal cone cell development (GO:0046549) | 2.64945433 |
| 124 | immunoglobulin mediated immune response (GO:0016064) | 2.63753139 |
| 125 | ribosomal small subunit assembly (GO:0000028) | 2.63296126 |
| 126 | triglyceride homeostasis (GO:0070328) | 2.63288410 |
| 127 | acylglycerol homeostasis (GO:0055090) | 2.63288410 |
| 128 | basic amino acid transport (GO:0015802) | 2.63134916 |
| 129 | platelet dense granule organization (GO:0060155) | 2.61578362 |
| 130 | tachykinin receptor signaling pathway (GO:0007217) | 2.61365726 |
| 131 | tyrosine metabolic process (GO:0006570) | 2.60597677 |
| 132 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.60449108 |
| 133 | photoreceptor cell maintenance (GO:0045494) | 2.60036258 |
| 134 | positive regulation of DNA recombination (GO:0045911) | 2.59840812 |
| 135 | sulfation (GO:0051923) | 2.59243944 |
| 136 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58935530 |
| 137 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58631892 |
| 138 | polyol transport (GO:0015791) | 2.57932695 |
| 139 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.57808259 |
| 140 | response to nitrosative stress (GO:0051409) | 2.57561344 |
| 141 | aspartate family amino acid catabolic process (GO:0009068) | 2.57377081 |
| 142 | cytokine biosynthetic process (GO:0042089) | 2.56359112 |
| 143 | neutrophil activation (GO:0042119) | 2.55922974 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.55913045 |
| 145 | signal peptide processing (GO:0006465) | 2.55866330 |
| 146 | xenobiotic catabolic process (GO:0042178) | 2.55427508 |
| 147 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.55017880 |
| 148 | phosphate ion transmembrane transport (GO:0035435) | 2.53434832 |
| 149 | toxin transport (GO:1901998) | 2.53335955 |
| 150 | mast cell activation (GO:0045576) | 2.53222504 |
| 151 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52659292 |
| 152 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.52543099 |
| 153 | positive regulation of defense response to virus by host (GO:0002230) | 2.52323604 |
| 154 | linoleic acid metabolic process (GO:0043651) | 2.51414346 |
| 155 | high-density lipoprotein particle remodeling (GO:0034375) | 2.51144626 |
| 156 | serotonin receptor signaling pathway (GO:0007210) | 2.49018298 |
| 157 | positive regulation of isotype switching (GO:0045830) | 2.48831364 |
| 158 | macrophage activation involved in immune response (GO:0002281) | 2.47194275 |
| 159 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.45887949 |
| 160 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45702371 |
| 161 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.44656157 |
| 162 | negative regulation of interleukin-12 production (GO:0032695) | 2.43804128 |
| 163 | superoxide anion generation (GO:0042554) | 2.43465419 |
| 164 | response to peptidoglycan (GO:0032494) | 2.42552293 |
| 165 | cellular response to interleukin-15 (GO:0071350) | 2.41562263 |
| 166 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.40768319 |
| 167 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.40444413 |
| 168 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.40100084 |
| 169 | positive regulation of mast cell degranulation (GO:0043306) | 2.40100084 |
| 170 | synapsis (GO:0007129) | 2.39860282 |
| 171 | L-fucose catabolic process (GO:0042355) | 2.36237108 |
| 172 | fucose catabolic process (GO:0019317) | 2.36237108 |
| 173 | L-fucose metabolic process (GO:0042354) | 2.36237108 |
| 174 | meiotic cell cycle (GO:0051321) | 2.35954938 |
| 175 | response to pheromone (GO:0019236) | 2.35462233 |
| 176 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.35242484 |
| 177 | myeloid cell activation involved in immune response (GO:0002275) | 2.34714634 |
| 178 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.34107162 |
| 179 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.33113788 |
| 180 | nucleotide transmembrane transport (GO:1901679) | 2.32484669 |
| 181 | cellular ketone body metabolic process (GO:0046950) | 2.30701878 |
| 182 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.30609114 |
| 183 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.30609114 |
| 184 | modulation by symbiont of host immune response (GO:0052553) | 2.30609114 |
| 185 | positive regulation by symbiont of host defense response (GO:0052509) | 2.30609114 |
| 186 | modulation by symbiont of host defense response (GO:0052031) | 2.30609114 |
| 187 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.30609114 |
| 188 | cytokine metabolic process (GO:0042107) | 2.30479757 |
| 189 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.30316165 |
| 190 | positive regulation of humoral immune response (GO:0002922) | 2.29855080 |
| 191 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.27899165 |
| 192 | negative T cell selection (GO:0043383) | 2.27524387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.91619156 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.01539316 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.82171767 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.70680553 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57794641 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.47321705 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.17534419 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.03258477 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.02398963 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.00250503 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.79729881 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.73145202 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67298187 |
| 14 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.64217311 |
| 15 | * GBX2_23144817_ChIP-Seq_PC3_Human | 2.62693399 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.43293116 |
| 17 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.37662665 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.31614070 |
| 19 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.30028155 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23928266 |
| 21 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.23625126 |
| 22 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.18495790 |
| 23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.16362983 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.11565137 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10481684 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08194941 |
| 27 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06731829 |
| 28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.05528986 |
| 29 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.03041207 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.98764464 |
| 31 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.98705892 |
| 32 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.98705892 |
| 33 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.98705892 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96935047 |
| 35 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96529015 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96400108 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.94485585 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.89050338 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.88356082 |
| 40 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87841486 |
| 41 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.86789849 |
| 42 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78973420 |
| 43 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.78472767 |
| 44 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.76903084 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76755976 |
| 46 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.73575995 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.70254266 |
| 48 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68178963 |
| 49 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67768090 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.66432026 |
| 51 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.66067639 |
| 52 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64672950 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.63983768 |
| 54 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.63969081 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.63450429 |
| 56 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.63153651 |
| 57 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.61989497 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59185581 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58604115 |
| 60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58585688 |
| 61 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58425979 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57995107 |
| 63 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.57310391 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.57310391 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.56020571 |
| 66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.54628980 |
| 67 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.53098322 |
| 68 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.52323211 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50302182 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.50110282 |
| 71 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.49741577 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.48528507 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.46585513 |
| 74 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45890842 |
| 75 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.45862542 |
| 76 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.43641126 |
| 77 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43538801 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43086915 |
| 79 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.42944313 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41841147 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.41160286 |
| 82 | FUS_26573619_Chip-Seq_HEK293_Human | 1.39432987 |
| 83 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.38381731 |
| 84 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38021655 |
| 85 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36312305 |
| 86 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.35815160 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35675914 |
| 88 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.35638044 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.34673128 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.34022510 |
| 91 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.33253206 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.33216940 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.33216940 |
| 94 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.32627776 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.32563172 |
| 96 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31134529 |
| 97 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30454589 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30257345 |
| 99 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.30154373 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.28247925 |
| 101 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28157906 |
| 102 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.27325541 |
| 103 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27237053 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26838322 |
| 105 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26778189 |
| 106 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26483600 |
| 107 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25889035 |
| 108 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25369685 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24554522 |
| 110 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.24351183 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23975404 |
| 112 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23598839 |
| 113 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23575685 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20635389 |
| 115 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.20569925 |
| 116 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20499189 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20214355 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.18562462 |
| 119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.17667114 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17574731 |
| 121 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17277444 |
| 122 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16953180 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.16714314 |
| 124 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.16353941 |
| 125 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.15992648 |
| 126 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15154309 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14316676 |
| 128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14224493 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14203873 |
| 130 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.13989522 |
| 131 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13929808 |
| 132 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13929808 |
| 133 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13774853 |
| 134 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13302187 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13166934 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12018510 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11633794 |
| 138 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.11423341 |
| 139 | MYB_26560356_Chip-Seq_TH2_Human | 1.11198898 |
| 140 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.10184504 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.09269480 |
| 142 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09241119 |
| 143 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09177380 |
| 144 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07433697 |
| 145 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06804679 |
| 146 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06103045 |
| 147 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06032469 |
| 148 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05646745 |
| 149 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05602101 |
| 150 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04481965 |
| 151 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.04118121 |
| 152 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.04110643 |
| 153 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.02971013 |
| 154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02859101 |
| 155 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02474885 |
| 156 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02109468 |
| 157 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.02030647 |
| 158 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.00670294 |
| 159 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00474477 |
| 160 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.96922412 |
| 161 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95491928 |
| 162 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.93480470 |
| 163 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93400753 |
| 164 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92887653 |
| 165 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92854495 |
| 166 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92623141 |
| 167 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90640473 |
| 168 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.88875652 |
| 169 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88351359 |
| 170 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88053853 |
| 171 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.87972975 |
| 172 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.87573721 |
| 173 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86345030 |
| 174 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84843740 |
| 175 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83874046 |
| 176 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.83812962 |
| 177 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83509077 |
| 178 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.83466270 |
| 179 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.83417364 |
| 180 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.83063411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.91907609 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.17958279 |
| 3 | MP0005365_abnormal_bile_salt | 4.41236629 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.11957331 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.97113689 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.81095142 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.40993709 |
| 8 | MP0006082_CNS_inflammation | 3.12388854 |
| 9 | MP0003724_increased_susceptibility_to | 3.06875167 |
| 10 | MP0003252_abnormal_bile_duct | 2.90878866 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.82976414 |
| 12 | MP0003195_calcinosis | 2.75071226 |
| 13 | MP0005332_abnormal_amino_acid | 2.61698886 |
| 14 | MP0005671_abnormal_response_to | 2.57597241 |
| 15 | MP0008058_abnormal_DNA_repair | 2.47908802 |
| 16 | MP0003011_delayed_dark_adaptation | 2.41394141 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.34692090 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.34323184 |
| 19 | MP0000569_abnormal_digit_pigmentation | 2.21390448 |
| 20 | MP0005310_abnormal_salivary_gland | 2.20765219 |
| 21 | MP0002254_reproductive_system_inflammat | 2.19837123 |
| 22 | MP0005451_abnormal_body_composition | 2.18871770 |
| 23 | MP0001835_abnormal_antigen_presentation | 2.18318942 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.09793304 |
| 25 | MP0001764_abnormal_homeostasis | 2.01561060 |
| 26 | MP0003693_abnormal_embryo_hatching | 1.97491646 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.95518749 |
| 28 | MP0001800_abnormal_humoral_immune | 1.93585831 |
| 29 | MP0001790_abnormal_immune_system | 1.92992223 |
| 30 | MP0005387_immune_system_phenotype | 1.92992223 |
| 31 | MP0009785_altered_susceptibility_to | 1.90157009 |
| 32 | MP0000685_abnormal_immune_system | 1.87722803 |
| 33 | MP0003868_abnormal_feces_composition | 1.86526570 |
| 34 | MP0003186_abnormal_redox_activity | 1.82673640 |
| 35 | MP0002419_abnormal_innate_immunity | 1.82505481 |
| 36 | MP0005670_abnormal_white_adipose | 1.82413637 |
| 37 | MP0003941_abnormal_skin_development | 1.81124405 |
| 38 | MP0002723_abnormal_immune_serum | 1.81002482 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.77739547 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.77304044 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.76923635 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.73351322 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.69963702 |
| 44 | MP0004133_heterotaxia | 1.68563238 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.67301630 |
| 46 | MP0003718_maternal_effect | 1.65413692 |
| 47 | MP0003111_abnormal_nucleus_morphology | 1.63032361 |
| 48 | MP0002420_abnormal_adaptive_immunity | 1.62345267 |
| 49 | MP0001819_abnormal_immune_cell | 1.61592774 |
| 50 | MP0010329_abnormal_lipoprotein_level | 1.61024415 |
| 51 | MP0005025_abnormal_response_to | 1.58934635 |
| 52 | MP0001188_hyperpigmentation | 1.53532158 |
| 53 | MP0005410_abnormal_fertilization | 1.52183375 |
| 54 | MP0004147_increased_porphyrin_level | 1.49032317 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.42420456 |
| 56 | MP0004043_abnormal_pH_regulation | 1.38873133 |
| 57 | MP0009840_abnormal_foam_cell | 1.36650522 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.32430962 |
| 59 | MP0003786_premature_aging | 1.30841026 |
| 60 | MP0000490_abnormal_crypts_of | 1.30790010 |
| 61 | MP0000566_synostosis | 1.30443621 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.29734215 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.26804568 |
| 64 | MP0003436_decreased_susceptibility_to | 1.26670659 |
| 65 | MP0005377_hearing/vestibular/ear_phenot | 1.25237888 |
| 66 | MP0003878_abnormal_ear_physiology | 1.25237888 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.25202025 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.24472205 |
| 69 | MP0002405_respiratory_system_inflammati | 1.24344793 |
| 70 | MP0009697_abnormal_copulation | 1.24025931 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.23927442 |
| 72 | MP0003646_muscle_fatigue | 1.19416389 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.19400741 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.17935900 |
| 75 | MP0000716_abnormal_immune_system | 1.16463909 |
| 76 | MP0000372_irregular_coat_pigmentation | 1.16061173 |
| 77 | MP0001984_abnormal_olfaction | 1.14300030 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.13979714 |
| 79 | MP0002102_abnormal_ear_morphology | 1.13889826 |
| 80 | MP0001765_abnormal_ion_homeostasis | 1.12299925 |
| 81 | MP0003950_abnormal_plasma_membrane | 1.12033509 |
| 82 | MP0003303_peritoneal_inflammation | 1.10927628 |
| 83 | MP0002136_abnormal_kidney_physiology | 1.10213643 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.10020559 |
| 85 | MP0000609_abnormal_liver_physiology | 1.09854543 |
| 86 | MP0005220_abnormal_exocrine_pancreas | 1.09274026 |
| 87 | MP0003879_abnormal_hair_cell | 1.07645344 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.03942035 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.03677667 |
| 90 | MP0004381_abnormal_hair_follicle | 1.02365930 |
| 91 | MP0003283_abnormal_digestive_organ | 1.00794555 |
| 92 | MP0002398_abnormal_bone_marrow | 0.98966641 |
| 93 | MP0005464_abnormal_platelet_physiology | 0.97647968 |
| 94 | MP0002277_abnormal_respiratory_mucosa | 0.97603873 |
| 95 | MP0010155_abnormal_intestine_physiology | 0.95607765 |
| 96 | MP0002876_abnormal_thyroid_physiology | 0.95334783 |
| 97 | MP0005395_other_phenotype | 0.94910400 |
| 98 | MP0009764_decreased_sensitivity_to | 0.94895581 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.93886892 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.92455509 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 0.90975681 |
| 102 | MP0003077_abnormal_cell_cycle | 0.90250507 |
| 103 | MP0005083_abnormal_biliary_tract | 0.89589847 |
| 104 | MP0008872_abnormal_physiological_respon | 0.89127774 |
| 105 | MP0004142_abnormal_muscle_tone | 0.88745434 |
| 106 | MP0002928_abnormal_bile_duct | 0.88435398 |
| 107 | MP0001756_abnormal_urination | 0.88281807 |
| 108 | MP0000371_diluted_coat_color | 0.88194225 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.87427976 |
| 110 | MP0002163_abnormal_gland_morphology | 0.86800134 |
| 111 | MP0001968_abnormal_touch/_nociception | 0.86549033 |
| 112 | MP0001293_anophthalmia | 0.86367493 |
| 113 | MP0002722_abnormal_immune_system | 0.85447658 |
| 114 | MP0002693_abnormal_pancreas_physiology | 0.84946770 |
| 115 | MP0001533_abnormal_skeleton_physiology | 0.84848226 |
| 116 | MP0001929_abnormal_gametogenesis | 0.84694991 |
| 117 | MP0005647_abnormal_sex_gland | 0.84175753 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.83347867 |
| 119 | MP0008004_abnormal_stomach_pH | 0.82845221 |
| 120 | MP0001661_extended_life_span | 0.81561175 |
| 121 | MP0001986_abnormal_taste_sensitivity | 0.80857186 |
| 122 | MP0008057_abnormal_DNA_replication | 0.80835941 |
| 123 | MP0004957_abnormal_blastocyst_morpholog | 0.80574694 |
| 124 | MP0009745_abnormal_behavioral_response | 0.79867670 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.79782155 |
| 126 | MP0003866_abnormal_defecation | 0.78704469 |
| 127 | MP0005253_abnormal_eye_physiology | 0.77634827 |
| 128 | MP0002429_abnormal_blood_cell | 0.77323536 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.76896620 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.76511610 |
| 131 | MP0006036_abnormal_mitochondrial_physio | 0.76282967 |
| 132 | MP0001119_abnormal_female_reproductive | 0.74577257 |
| 133 | MP0002272_abnormal_nervous_system | 0.73458823 |
| 134 | MP0010386_abnormal_urinary_bladder | 0.73335614 |
| 135 | MP0009046_muscle_twitch | 0.73035936 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72887654 |
| 137 | MP0000538_abnormal_urinary_bladder | 0.71463165 |
| 138 | MP0002132_abnormal_respiratory_system | 0.71108394 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.71094230 |
| 140 | MP0002736_abnormal_nociception_after | 0.71040882 |
| 141 | MP0003698_abnormal_male_reproductive | 0.70989692 |
| 142 | MP0005389_reproductive_system_phenotype | 0.70838209 |
| 143 | MP0005266_abnormal_metabolism | 0.70524119 |
| 144 | MP0000579_abnormal_nail_morphology | 0.70021215 |
| 145 | MP0005174_abnormal_tail_pigmentation | 0.69400671 |
| 146 | MP0000598_abnormal_liver_morphology | 0.69132561 |
| 147 | MP0009763_increased_sensitivity_to | 0.68528759 |
| 148 | MP0009379_abnormal_foot_pigmentation | 0.67497887 |
| 149 | MP0006072_abnormal_retinal_apoptosis | 0.66466931 |
| 150 | MP0008260_abnormal_autophagy | 0.66378872 |
| 151 | MP0000427_abnormal_hair_cycle | 0.66370934 |
| 152 | MP0008469_abnormal_protein_level | 0.65426151 |
| 153 | MP0001324_abnormal_eye_pigmentation | 0.64655297 |
| 154 | MP0008995_early_reproductive_senescence | 0.64282272 |
| 155 | MP0005501_abnormal_skin_physiology | 0.64234268 |
| 156 | MP0001873_stomach_inflammation | 0.63084761 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.60950135 |
| 158 | MP0005084_abnormal_gallbladder_morpholo | 0.60741640 |
| 159 | MP0008007_abnormal_cellular_replicative | 0.60164109 |
| 160 | MP0002938_white_spotting | 0.57496481 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.56160892 |
| 162 | MP0000383_abnormal_hair_follicle | 0.55963753 |
| 163 | MP0003638_abnormal_response/metabolism_ | 0.55802195 |
| 164 | MP0000462_abnormal_digestive_system | 0.55241635 |
| 165 | MP0000477_abnormal_intestine_morphology | 0.54444685 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.50257075 |
| 2 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.49926745 |
| 3 | Chromsome breakage (HP:0040012) | 4.06287103 |
| 4 | Stomatitis (HP:0010280) | 4.00776504 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.95585730 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.87551960 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.87423031 |
| 8 | Hyperglycinuria (HP:0003108) | 3.79686745 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.52535193 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.46957412 |
| 11 | Optic neuritis (HP:0100653) | 3.43261078 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.43261078 |
| 13 | Proximal tubulopathy (HP:0000114) | 3.35375427 |
| 14 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28326671 |
| 15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24824562 |
| 16 | Reticulocytopenia (HP:0001896) | 3.23989326 |
| 17 | Generalized aminoaciduria (HP:0002909) | 3.23479653 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 3.17645895 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17645895 |
| 20 | Pancreatic cysts (HP:0001737) | 3.05802413 |
| 21 | Hyperglycinemia (HP:0002154) | 3.02877988 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.01161267 |
| 23 | Myositis (HP:0100614) | 3.00810569 |
| 24 | Microvesicular hepatic steatosis (HP:0001414) | 2.99431075 |
| 25 | Attenuation of retinal blood vessels (HP:0007843) | 2.96344134 |
| 26 | Orchitis (HP:0100796) | 2.92520506 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 2.89327687 |
| 28 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.88041216 |
| 29 | Abnormality of alanine metabolism (HP:0010916) | 2.88041216 |
| 30 | Hyperalaninemia (HP:0003348) | 2.88041216 |
| 31 | Hypomagnesemia (HP:0002917) | 2.87618527 |
| 32 | Hyperactive renin-angiotensin system (HP:0000841) | 2.87425990 |
| 33 | Abnormality of serum amino acid levels (HP:0003112) | 2.86070809 |
| 34 | Stomach cancer (HP:0012126) | 2.83085888 |
| 35 | Prolonged partial thromboplastin time (HP:0003645) | 2.80965991 |
| 36 | Gout (HP:0001997) | 2.80069326 |
| 37 | Increased circulating renin level (HP:0000848) | 2.76098333 |
| 38 | Hyperammonemia (HP:0001987) | 2.70268661 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.69593747 |
| 40 | Keratoconjunctivitis (HP:0001096) | 2.69478083 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 2.67526634 |
| 42 | True hermaphroditism (HP:0010459) | 2.64397748 |
| 43 | Congenital sensorineural hearing impairment (HP:0008527) | 2.60674833 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 2.59722302 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 2.59722302 |
| 46 | Increased purine levels (HP:0004368) | 2.59572025 |
| 47 | Hyperuricemia (HP:0002149) | 2.59572025 |
| 48 | Polyuria (HP:0000103) | 2.55590075 |
| 49 | Renal cortical cysts (HP:0000803) | 2.55270975 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.54721712 |
| 51 | Recurrent bacterial skin infections (HP:0005406) | 2.52232591 |
| 52 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.51739402 |
| 53 | Abnormality of the preputium (HP:0100587) | 2.50090038 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 2.49384215 |
| 55 | Gaze-evoked nystagmus (HP:0000640) | 2.48574055 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.48282476 |
| 57 | Glycosuria (HP:0003076) | 2.48282476 |
| 58 | Abnormal urine output (HP:0012590) | 2.47765577 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47084694 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.46708888 |
| 61 | Abolished electroretinogram (ERG) (HP:0000550) | 2.46626908 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.46508764 |
| 63 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46508764 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.46080833 |
| 65 | Chronic hepatic failure (HP:0100626) | 2.44600562 |
| 66 | Ketosis (HP:0001946) | 2.44599121 |
| 67 | Alkalosis (HP:0001948) | 2.42596206 |
| 68 | Duplicated collecting system (HP:0000081) | 2.41973973 |
| 69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.39811911 |
| 70 | Joint hemorrhage (HP:0005261) | 2.38487849 |
| 71 | Hypobetalipoproteinemia (HP:0003563) | 2.36717954 |
| 72 | Recurrent abscess formation (HP:0002722) | 2.35476331 |
| 73 | Fat malabsorption (HP:0002630) | 2.35054268 |
| 74 | Widely patent fontanelles and sutures (HP:0004492) | 2.34859711 |
| 75 | Xanthomatosis (HP:0000991) | 2.34490357 |
| 76 | Prostate neoplasm (HP:0100787) | 2.34186369 |
| 77 | Abnormality of chromosome stability (HP:0003220) | 2.34101646 |
| 78 | Meckel diverticulum (HP:0002245) | 2.32893923 |
| 79 | Osteomalacia (HP:0002749) | 2.31597292 |
| 80 | Abnormality of the renal collecting system (HP:0004742) | 2.31489956 |
| 81 | Abnormality of renal excretion (HP:0011036) | 2.31265660 |
| 82 | Metabolic alkalosis (HP:0200114) | 2.31161951 |
| 83 | Decreased circulating renin level (HP:0003351) | 2.29956473 |
| 84 | Hypothermia (HP:0002045) | 2.28671295 |
| 85 | Recurrent fungal infections (HP:0002841) | 2.28587698 |
| 86 | Medial flaring of the eyebrow (HP:0010747) | 2.27863355 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27770425 |
| 88 | Nephronophthisis (HP:0000090) | 2.27281816 |
| 89 | Hypokalemic alkalosis (HP:0001949) | 2.25118264 |
| 90 | Nausea (HP:0002018) | 2.24475523 |
| 91 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.24374114 |
| 92 | Renal tubular acidosis (HP:0001947) | 2.24182425 |
| 93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23736448 |
| 94 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23736448 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.23463420 |
| 96 | Rickets (HP:0002748) | 2.20517444 |
| 97 | Vacuolated lymphocytes (HP:0001922) | 2.20410640 |
| 98 | Abnormality of the ileum (HP:0001549) | 2.20149044 |
| 99 | Hemoptysis (HP:0002105) | 2.19535063 |
| 100 | Hematochezia (HP:0002573) | 2.19457017 |
| 101 | IgG deficiency (HP:0004315) | 2.18815986 |
| 102 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.18642106 |
| 103 | Albinism (HP:0001022) | 2.18270489 |
| 104 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.18111525 |
| 105 | Thyroiditis (HP:0100646) | 2.17486791 |
| 106 | Abnormality of T cell number (HP:0011839) | 2.17380991 |
| 107 | Keratoconjunctivitis sicca (HP:0001097) | 2.17317721 |
| 108 | Distal lower limb muscle weakness (HP:0009053) | 2.15347520 |
| 109 | Abnormality of DNA repair (HP:0003254) | 2.14899397 |
| 110 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.14794597 |
| 111 | Abnormality of macular pigmentation (HP:0008002) | 2.14731319 |
| 112 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.14517297 |
| 113 | Anal stenosis (HP:0002025) | 2.13935982 |
| 114 | Birth length less than 3rd percentile (HP:0003561) | 2.12959896 |
| 115 | Abnormality of chloride homeostasis (HP:0011422) | 2.11576749 |
| 116 | Abnormality of B cell number (HP:0010975) | 2.11301418 |
| 117 | Vasculitis (HP:0002633) | 2.09045794 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.08932534 |
| 119 | Decreased central vision (HP:0007663) | 2.08288631 |
| 120 | Metabolic acidosis (HP:0001942) | 2.08247914 |
| 121 | Lethargy (HP:0001254) | 2.07689375 |
| 122 | Autoimmune thrombocytopenia (HP:0001973) | 2.07656620 |
| 123 | Constricted visual fields (HP:0001133) | 2.07105598 |
| 124 | Renal salt wasting (HP:0000127) | 2.07079449 |
| 125 | Vascular calcification (HP:0004934) | 2.05974123 |
| 126 | Reduced antithrombin III activity (HP:0001976) | 2.05552480 |
| 127 | Confusion (HP:0001289) | 2.04113670 |
| 128 | Increased IgM level (HP:0003496) | 2.02648785 |
| 129 | Tetany (HP:0001281) | 2.02438950 |
| 130 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02389375 |
| 131 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02389375 |
| 132 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02389375 |
| 133 | Chronic diarrhea (HP:0002028) | 2.02203040 |
| 134 | Ketoacidosis (HP:0001993) | 2.01470598 |
| 135 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.01226061 |
| 136 | Hypoplasia of the fovea (HP:0007750) | 2.01226061 |
| 137 | Encephalitis (HP:0002383) | 2.00758684 |
| 138 | Severe visual impairment (HP:0001141) | 1.99851237 |
| 139 | Dyschromatopsia (HP:0007641) | 1.99040885 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.98840360 |
| 141 | Abnormality of the renal medulla (HP:0100957) | 1.98752351 |
| 142 | Severe combined immunodeficiency (HP:0004430) | 1.97439285 |
| 143 | Pulmonary infiltrates (HP:0002113) | 1.96787490 |
| 144 | Type I transferrin isoform profile (HP:0003642) | 1.95858040 |
| 145 | Recurrent skin infections (HP:0001581) | 1.95378002 |
| 146 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.95327828 |
| 147 | Abnormality of eosinophils (HP:0001879) | 1.95004725 |
| 148 | Gastrointestinal infarctions (HP:0005244) | 1.94666158 |
| 149 | Macular degeneration (HP:0000608) | 1.93342169 |
| 150 | Clubbing of toes (HP:0100760) | 1.92642881 |
| 151 | Leukocytosis (HP:0001974) | 1.91227781 |
| 152 | Hyperaldosteronism (HP:0000859) | 1.90565323 |
| 153 | Mediastinal lymphadenopathy (HP:0100721) | 1.90132923 |
| 154 | Pustule (HP:0200039) | 1.89580165 |
| 155 | Abnormality of the renal cortex (HP:0011035) | 1.88560799 |
| 156 | Steatorrhea (HP:0002570) | 1.88014408 |
| 157 | Abnormality of T cells (HP:0002843) | 1.86202641 |
| 158 | Opisthotonus (HP:0002179) | 1.85806646 |
| 159 | Abnormality of T cell physiology (HP:0011840) | 1.84295630 |
| 160 | Autoimmune hemolytic anemia (HP:0001890) | 1.84126949 |
| 161 | Abnormality of the fovea (HP:0000493) | 1.84121418 |
| 162 | Bile duct proliferation (HP:0001408) | 1.83958720 |
| 163 | Abnormal biliary tract physiology (HP:0012439) | 1.83958720 |
| 164 | Epidermoid cyst (HP:0200040) | 1.83290968 |
| 165 | Hyperventilation (HP:0002883) | 1.82379015 |
| 166 | Hyponatremia (HP:0002902) | 1.82112163 |
| 167 | Eczematoid dermatitis (HP:0000976) | 1.82104683 |
| 168 | Keratitis (HP:0000491) | 1.81164705 |
| 169 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.81118105 |
| 170 | Enlarged kidneys (HP:0000105) | 1.80487471 |
| 171 | Polydipsia (HP:0001959) | 1.79008492 |
| 172 | Abnormal drinking behavior (HP:0030082) | 1.79008492 |
| 173 | Abnormal spermatogenesis (HP:0008669) | 1.77963273 |
| 174 | Nephrocalcinosis (HP:0000121) | 1.77841402 |
| 175 | Eosinophilia (HP:0001880) | 1.77777407 |
| 176 | Congenital hepatic fibrosis (HP:0002612) | 1.77242890 |
| 177 | T lymphocytopenia (HP:0005403) | 1.77236040 |
| 178 | Megaloblastic anemia (HP:0001889) | 1.76249494 |
| 179 | Breast hypoplasia (HP:0003187) | 1.76245464 |
| 180 | Renal tubular dysfunction (HP:0000124) | 1.76044177 |
| 181 | Combined immunodeficiency (HP:0005387) | 1.75202858 |
| 182 | Anorexia (HP:0002039) | 1.74264284 |
| 183 | Episodic fever (HP:0001954) | 1.72246667 |
| 184 | Photophobia (HP:0000613) | 1.71127562 |
| 185 | Progressive cerebellar ataxia (HP:0002073) | 1.68576894 |
| 186 | Polyneuropathy (HP:0001271) | 1.64613816 |
| 187 | Oligodactyly (hands) (HP:0001180) | 1.63176944 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZAK | 3.59324945 |
| 2 | BCKDK | 3.45117538 |
| 3 | WNK3 | 3.16292500 |
| 4 | EPHA2 | 3.09096959 |
| 5 | STK16 | 3.05706425 |
| 6 | MAP4K2 | 2.94573430 |
| 7 | TNIK | 2.73471094 |
| 8 | EIF2AK2 | 2.51952850 |
| 9 | TTK | 2.42747335 |
| 10 | WEE1 | 2.15223344 |
| 11 | VRK1 | 2.11318563 |
| 12 | GRK1 | 2.10084947 |
| 13 | BUB1 | 2.08833892 |
| 14 | AKT3 | 1.99663552 |
| 15 | INSRR | 1.99604987 |
| 16 | PLK4 | 1.96787954 |
| 17 | NUAK1 | 1.92775918 |
| 18 | TLK1 | 1.91803873 |
| 19 | FLT3 | 1.90424254 |
| 20 | RPS6KB2 | 1.88858888 |
| 21 | IRAK3 | 1.88766053 |
| 22 | MAP3K13 | 1.81294463 |
| 23 | BMPR1B | 1.76770717 |
| 24 | STK38L | 1.72993606 |
| 25 | SRPK1 | 1.69242755 |
| 26 | TAOK3 | 1.66943578 |
| 27 | OXSR1 | 1.63537013 |
| 28 | TAOK2 | 1.60339186 |
| 29 | EIF2AK1 | 1.50984061 |
| 30 | TRIM28 | 1.44403104 |
| 31 | NEK1 | 1.43927702 |
| 32 | BMPR2 | 1.43205680 |
| 33 | EIF2AK3 | 1.42119420 |
| 34 | FRK | 1.34904022 |
| 35 | TEC | 1.30684193 |
| 36 | PASK | 1.30062631 |
| 37 | GRK6 | 1.27410655 |
| 38 | WNK4 | 1.27341405 |
| 39 | MUSK | 1.26001468 |
| 40 | FES | 1.24796195 |
| 41 | PLK1 | 1.24656285 |
| 42 | ATR | 1.17690563 |
| 43 | CDK7 | 1.17640486 |
| 44 | MAPK13 | 1.14580695 |
| 45 | CDK19 | 1.10741681 |
| 46 | NEK2 | 1.09993960 |
| 47 | PBK | 1.09611323 |
| 48 | STK24 | 1.08660103 |
| 49 | MAPKAPK3 | 1.07478074 |
| 50 | ITK | 1.07094434 |
| 51 | STK4 | 1.07074731 |
| 52 | DYRK3 | 1.06402785 |
| 53 | MAP2K6 | 1.04669166 |
| 54 | CSK | 1.03587243 |
| 55 | SYK | 0.98939211 |
| 56 | TYK2 | 0.97911713 |
| 57 | CAMKK2 | 0.97590970 |
| 58 | TGFBR2 | 0.95856955 |
| 59 | JAK1 | 0.95534207 |
| 60 | PIK3CG | 0.95251532 |
| 61 | AURKB | 0.93077786 |
| 62 | BRD4 | 0.91991779 |
| 63 | MAP3K4 | 0.91781119 |
| 64 | CHEK2 | 0.90032248 |
| 65 | NLK | 0.89355960 |
| 66 | CDK12 | 0.88143357 |
| 67 | GRK7 | 0.86985212 |
| 68 | BLK | 0.85284299 |
| 69 | MARK3 | 0.85158977 |
| 70 | MAP3K14 | 0.85127021 |
| 71 | ADRBK2 | 0.84049447 |
| 72 | STK39 | 0.83363637 |
| 73 | PRKCQ | 0.83302238 |
| 74 | IRAK1 | 0.81482909 |
| 75 | RIPK4 | 0.81187022 |
| 76 | SIK3 | 0.80636182 |
| 77 | MST4 | 0.80368572 |
| 78 | TRPM7 | 0.80096494 |
| 79 | MAPK15 | 0.79244066 |
| 80 | PRKCI | 0.76358516 |
| 81 | PDK2 | 0.75590734 |
| 82 | YES1 | 0.72907708 |
| 83 | TXK | 0.71185343 |
| 84 | NTRK3 | 0.71104118 |
| 85 | PTK2B | 0.70977290 |
| 86 | CDC7 | 0.69574064 |
| 87 | LCK | 0.69274302 |
| 88 | PRKAA2 | 0.68872533 |
| 89 | FER | 0.68545087 |
| 90 | AURKA | 0.68520819 |
| 91 | IKBKB | 0.68020496 |
| 92 | PLK3 | 0.65823411 |
| 93 | KIT | 0.65681368 |
| 94 | MAP3K12 | 0.65647562 |
| 95 | ERBB4 | 0.65250946 |
| 96 | IRAK4 | 0.64914414 |
| 97 | TGFBR1 | 0.64581659 |
| 98 | FGFR4 | 0.64348024 |
| 99 | NEK6 | 0.63947055 |
| 100 | MAPK11 | 0.63268077 |
| 101 | DAPK2 | 0.62378818 |
| 102 | IRAK2 | 0.62036448 |
| 103 | ACVR1B | 0.62035560 |
| 104 | ADRBK1 | 0.61720952 |
| 105 | MAP4K1 | 0.60070289 |
| 106 | BRSK2 | 0.59912896 |
| 107 | STK3 | 0.59888674 |
| 108 | FGR | 0.58264738 |
| 109 | PRKCE | 0.56229108 |
| 110 | TBK1 | 0.55813513 |
| 111 | KDR | 0.55557879 |
| 112 | BTK | 0.54298076 |
| 113 | PDK1 | 0.53393803 |
| 114 | MAP2K3 | 0.53179682 |
| 115 | JAK3 | 0.52988519 |
| 116 | HCK | 0.52719750 |
| 117 | MATK | 0.52606021 |
| 118 | AKT2 | 0.51176292 |
| 119 | PINK1 | 0.50881480 |
| 120 | LATS1 | 0.50264661 |
| 121 | RPS6KA5 | 0.50152209 |
| 122 | DYRK2 | 0.49222531 |
| 123 | PIK3CA | 0.46910014 |
| 124 | CHUK | 0.46025227 |
| 125 | JAK2 | 0.45329292 |
| 126 | ATM | 0.45086860 |
| 127 | PLK2 | 0.44258721 |
| 128 | PIM1 | 0.43946642 |
| 129 | SIK1 | 0.43112669 |
| 130 | ZAP70 | 0.42975127 |
| 131 | CDK4 | 0.41772391 |
| 132 | MAP3K8 | 0.41004309 |
| 133 | LYN | 0.40375928 |
| 134 | ABL1 | 0.40275410 |
| 135 | MAP3K11 | 0.39930960 |
| 136 | MAP3K3 | 0.39837332 |
| 137 | PKN1 | 0.38851225 |
| 138 | TIE1 | 0.38569155 |
| 139 | MAPK7 | 0.38424566 |
| 140 | CDK3 | 0.38127809 |
| 141 | TNK2 | 0.38100250 |
| 142 | CSNK2A1 | 0.37709765 |
| 143 | IKBKE | 0.36814554 |
| 144 | CSNK2A2 | 0.35690371 |
| 145 | CSF1R | 0.33995803 |
| 146 | NME2 | 0.33941919 |
| 147 | IGF1R | 0.32310567 |
| 148 | ERBB2 | 0.31241842 |
| 149 | ERBB3 | 0.31074573 |
| 150 | STK10 | 0.30825056 |
| 151 | MAP3K6 | 0.30215687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.68562746 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.60069409 |
| 3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.50121547 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.45738024 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.45301840 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.43760409 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.36369042 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.29169224 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.25950657 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24153242 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23648984 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.20077418 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18081165 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.12367704 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.11533579 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.11063729 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08761531 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.01936832 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.99272581 |
| 20 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.98889917 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.96935192 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.89844365 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89833033 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.87723727 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87597807 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83514767 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82766911 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.81693671 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.81433862 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77681931 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77536766 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.73321895 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.70365081 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68012387 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.67681078 |
| 36 | DNA replication_Homo sapiens_hsa03030 | 1.65252787 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62367477 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.61099217 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55615524 |
| 40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54276789 |
| 41 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52363106 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52010545 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51153991 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.49390591 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.49223031 |
| 46 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44624350 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.40881751 |
| 48 | Homologous recombination_Homo sapiens_hsa03440 | 1.39948042 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35806806 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.35501293 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.34794796 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34541329 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34071774 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.33942006 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31939416 |
| 56 | Olfactory transduction_Homo sapiens_hsa04740 | 1.30554615 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.30336609 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 1.29734490 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.29346878 |
| 60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28951483 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27175548 |
| 62 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27105502 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26356890 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.26170320 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25687113 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25494868 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25300199 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24746525 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24666531 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 1.23804962 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23101457 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22441141 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.21616329 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19417503 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 1.17557707 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17466899 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16443504 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15651122 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 1.14897469 |
| 80 | Ribosome_Homo sapiens_hsa03010 | 1.14525423 |
| 81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12197720 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11101830 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 1.09135413 |
| 84 | Legionellosis_Homo sapiens_hsa05134 | 1.08519298 |
| 85 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.08147027 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07453221 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07314303 |
| 88 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.05142344 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04696223 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04569827 |
| 91 | RNA polymerase_Homo sapiens_hsa03020 | 1.01884935 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01844076 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01647769 |
| 94 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00386199 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99817275 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99099673 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98707770 |
| 98 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.97659653 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97033930 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.96941685 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95288401 |
| 102 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91211745 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90864037 |
| 104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.90320140 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89575601 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87208255 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86928009 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84893944 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.83415060 |
| 110 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83343107 |
| 111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80954171 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.80737001 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80694125 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.80629464 |
| 115 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.79385219 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78584519 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76003070 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75580912 |
| 119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.72511891 |
| 120 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72441196 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69445451 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.68006638 |
| 123 | Purine metabolism_Homo sapiens_hsa00230 | 0.67568176 |
| 124 | Taste transduction_Homo sapiens_hsa04742 | 0.65778030 |
| 125 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65735851 |
| 126 | Pertussis_Homo sapiens_hsa05133 | 0.65175784 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64341807 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64151537 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62163572 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61048501 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.60540480 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.60514874 |
| 133 | Malaria_Homo sapiens_hsa05144 | 0.60199466 |
| 134 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58600722 |
| 135 | Morphine addiction_Homo sapiens_hsa05032 | 0.57907619 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56895359 |
| 137 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.56627942 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56237987 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55749590 |
| 140 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55571975 |
| 141 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55560223 |
| 142 | Nicotine addiction_Homo sapiens_hsa05033 | 0.55421705 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54776887 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54049017 |
| 145 | Proteasome_Homo sapiens_hsa03050 | 0.53632196 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.53432642 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53140859 |
| 148 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52831886 |
| 149 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.52601657 |
| 150 | Protein export_Homo sapiens_hsa03060 | 0.51424822 |
| 151 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50685913 |
| 152 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50310947 |
| 153 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49645016 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.48592096 |
| 155 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47967292 |
| 156 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46995677 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45173805 |
| 158 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42278229 |
| 159 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39297068 |
| 160 | Cell cycle_Homo sapiens_hsa04110 | 0.30360798 |
| 161 | Spliceosome_Homo sapiens_hsa03040 | 0.29858433 |
| 162 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.29656268 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.29366078 |
| 164 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28055066 |
| 165 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19237279 |

